Plott Ronald Todd Insider Trades & Stock Holdings
Plott Ronald Todd, Director at Phio Pharmaceuticals Corp. has 2 Form 4 trades on file since Sep 28, 2026. Open-market activity: 2 purchases ($10.35K) and 0 sales ($0), net +$10.35K. Latest filing: acquired 5K shares of $PHIO on Sep 29, 2026 at $1.04.
- Trades on file
- 2
- Open-market bought
- $10.35K
- Open-market sold
- $0
- Net open-market
- +$10.35K
- Latest filing
- Sep 29, 2026
All insider trades by Plott Ronald Todd
| Date | Ticker | Type | Shares | Price | Value | Owned after | ΔOwn | 1W | 1M | 6M | Role | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $PHIO | Buy (Open-market buy) | 5K | $1.04 | $5.20K | Director | — | |||||||
| $PHIO | Buy (Open-market buy) | 5K | $1.03 | $5.15K | Director | — |
"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.
Stocks Plott Ronald Todd traded
Frequently asked questions
Has Plott Ronald Todd been buying or selling stock?
Plott Ronald Todd has 2 open-market purchases and 0 open-market sales on file, net +$10.35K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.
What was Plott Ronald Todd's latest insider trade?
acquired 5K shares of $PHIO on Sep 29, 2026 at $1.04.
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.